InsidersTradesSigma
Track the Pharmanutra Pharmanutra - PHN - Orientamenti del CDA Agli Azionisti Sulla Futura Dimensione e Composizione del Nuovo CDA - Nomina Dell’investor Relator share price and the full management transaction log of the company, a listed issuer based in Italy. Shares are listed on the IT market, under the oversight of Consob. Operating in the Health Care sector, Pharmanutra Pharmanutra - PHN - Orientamenti del CDA Agli Azionisti Sulla Futura Dimensione e Composizione del Nuovo CDA - Nomina Dell’investor Relator has logged 0 reports. Market capitalisation: €794.7m. The full history is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,570 of 29,064 companies
61.7
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About Pharmanutra Pharmanutra - PHN - Orientamenti del CDA Agli Azionisti Sulla Futura Dimensione e Composizione del Nuovo CDA - Nomina Dell’investor Relator
Pharmanutra is a company specialized in the health and pharmaceutical sector, listed on the XMIL market. It focuses on developing innovative health solutions, including nutraceutical products.